Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06779617 · ClinicalTrials.gov registry record · NA
UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial
A NA study, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- NA
- Development phase
- 150,000
- Enrollment target
NCT06779617 is a NA study that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 150,000 participants.
The verdict
NCT06779617, a NA study, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- NA
- Development phase
- 150,000 participants
- Enrollment target
Study Summary
This study is designed to test two new risk scores - one designed to predict a patient's four-hour risk of developing sepsis and one designed to predict a patient's four-hour risk of deterioration (cardiac arrest, death, unplanned ICU transfer, or rapid response team call). The goal of this study is to improve provider awareness of a patient's risk of these two negative outcomes by providing them with new risk scores. The primary outcome will be the time from when the risk score becomes elevated to when vital signs such as heart rate or blood pressure are measured, suggesting an increased awareness.
Interventions
- DEVICE SEPSys
- DEVICE RESCUE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150,000 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06779617
The ClinicalTrials.gov registry entry for NCT06779617 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SEPSys is the first listed.
NCT06779617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06779617 about?
NCT06779617 is a clinical study titled "UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial". This study is designed to test two new risk scores - one designed to predict a patient's four-hour risk of developing sepsis and one designed to predict a patient's four-hour risk of deterioration (cardiac arrest, death, unplanned ICU transfer, or rapid response team call). The goal of this study is...
What is the current status of trial NCT06779617?
This trial is currently recruiting. It is a NA study. The enrollment target is 150,000 participants. The study started on 2026-02-01. Estimated completion is 2028-12.
What interventions are being tested in trial NCT06779617?
The interventions under investigation include: SEPSys (DEVICE), RESCUE (DEVICE).
Who is sponsoring clinical trial NCT06779617?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.